2022;14(1):e1740
These reports support the idea that GLP-1 RAs affect EGD adequacy regardless of the presence of T2DM [11]
People with a personal or family history of medullary thyroid carcinoma (MTC) or who have multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take Wegovy
However, stopping treatment should still be discussed with your healthcare provider because your recovery goals, symptoms, and overall health are unique
2026, GLP-1 face is on every consult Ozempic, Mounjaro, and Wegovy weight loss has produced a new aesthetic concern set: hollowing in the temples, mid-face, jawline, and tear troughs at a faster rate than aging alone would produce
Key Takeaways: GLP-1 use among patients newly diagnosed with Polycystic Ovary Syndrome (PCOS) without type 2 diabetes rose 6.7-fold between 2020 and 2024